Clinical Trials Directory

Trials / Completed

CompletedNCT01276691

Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Illinois at Urbana-Champaign · Academic / Other
Sex
Male
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that 1. an acute treatment of low-dose aspirin will lead to a) decreased resting platelet activation, platelet aggregation, and clotting potential, b) increased fibrinolytic potential following fire fighting, c) no significant effect on endothelial function or arterial stiffness versus the placebo condition. 2. chronic treatment with low-dose aspirin will lead to a) decreased resting and fire fighting induced platelet activation, platelet aggregation, clotting potential, b) increased fibrinolytic potential, and c) increased endothelial function and decreased arterial stiffness in response to live fire fighting versus the placebo condition. 3. short-term fire fighting activity will result in: a) a reduction in arterial function (reduced endothelial function, increased augmentation index and an attenuated arterial stiffness response); b) a disruption in hemostasis that is characterized by an increase in platelet number and function, an increased coagulatory potential and altered fibrinolytic potential; and c) an elevation in procoagulatory cytokines, systemic inflammation, monokine chemoattractant protein, and matrix metalloproteinases.

Conditions

Interventions

TypeNameDescription
DRUG81 mg enteric coated aspirin81 mg enteric coated aspirin will be provided both as an acute dosage immediately prior to firefighting (1 hour pre-activity) and as a 14 day dosage prior to firefighting

Timeline

Start date
2011-02-01
Primary completion
2011-10-01
Completion
2012-12-01
First posted
2011-01-13
Last updated
2020-07-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01276691. Inclusion in this directory is not an endorsement.